Tislelizumab plus chemotherapy versus chemotherapy as first-line treatment for extensive-stage small cell lung cancer: A cost-effectiveness analysis

• Zhiwei Zheng,

  Roles Project administration, Writing – original draft, Writing – review & editing

  Affiliation Department of Pharmacy, Cancer Hospital of Shantou University Medical College, Shantou, China

  https://orcid.org/0000-0002-7815-3221

  ⨯
• Huide Zhu ,

  Roles Data curation, Investigation, Methodology, Writing – review & editing

  * E-mail: zhuhuide_2009@163.com (HZ); lfang1@stu.edu.cn (LF)

  Affiliation Department of Pharmacy, Cancer Hospital of Shantou University Medical College, Shantou, China

  ⨯
• Ling Fang

  Roles Data curation, Software

  * E-mail: zhuhuide_2009@163.com (HZ); lfang1@stu.edu.cn (LF)

  Affiliation Department of Pharmacy, Cancer Hospital of Shantou University Medical College, Shantou, China

  ⨯